resTORbio Inc. (NASDAQ: TORC) is 67.11% higher on its value in year-to-date trading and has touched a low of $0.86 and a high of $11.96 in the current 52-week trading range. The TORC stock was last observed hovering at around $2.49 in the recent trading session, with the current loss setting it -0.18%.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
At last check, trading at $2.31, the stock is 5.35% and 16.08% above its SMA20 and SMA50 respectively. However, with a current trading volume of 0.47 million and changing -7.23% at the moment leaves the stock -17.87% off its SMA200. TORC registered -75.75% loss for a year compared to 6-month gain of 70.55%. The firm has a 50-day simple moving average (SMA 50) of $2.1518 and a 200-day simple moving average (SMA200) of $1.5488.
The stock witnessed a 16.63% loss in the last 1 month and extending the period to 3 months gives it a 141.75%, and is 14.22% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.33% over the week and 9.45% over the month.
Distance from 52-week low is 168.60% and -80.69% from its 52-week high.
resTORbio Inc. (TORC) Analyst Forecasts
resTORbio Inc. quarterly earnings per share for the current quarter are estimated at -$0.25.The EPS is expected to shrink by -69.50% this year.
resTORbio Inc. (TORC) Top Institutional Holders
90 institutions hold shares in resTORbio Inc. (TORC), with 5.81M shares held by insiders accounting for 15.95% while institutional investors hold 47.01% of the company’s shares. The shares outstanding are 36.45M, and float is at 30.63M with Short Float at 2.43%. Institutions hold 39.51% of the Float.
The top institutional shareholder in the company is Orbimed Advisors LLC. with over 4.83 million shares valued at $4.98 million. The investor’s holdings represent 13.25% of the TORC Shares outstanding. As of Mar 30, 2020, the second largest holder is Blackrock Inc. with 1.58 million shares valued at $1.63 million to account for 4.34% of the shares outstanding. The other top investors are Baillie Gifford and Company which holds 1.27 million shares representing 3.49% and valued at over $1.31 million, while Acadian Asset Management holds 2.58% of the shares totaling 0.94 million with a market value of $0.97 million.
resTORbio Inc. (TORC) Insider Activity
A total of 0 insider transactions have happened at resTORbio Inc. (TORC) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider sale by PureTech Health LLC, the company’s 10% Owner. SEC filings show that PureTech Health LLC sold 6,161,531 shares of the company’s common stock on Dec 18 at a price of $1.20 per share for a total of $7.39 million. Following the sale, the insider now owns 2.12 million shares.
resTORbio Inc. disclosed in a document filed with the SEC on Dec 13 that PureTech Health LLC (10% Owner) sold a total of 205,763 shares of the company’s common stock. The trade occurred on Dec 13 and was made at $1.24 per share for $0.26 million. Following the transaction, the insider now directly holds 8.28 million shares of the TORC stock.
Still, SEC filings show that on Dec 12, PureTech Health LLC (10% Owner) disposed off 385,884 shares at an average price of $1.25 for $0.48 million. The insider now directly holds 8,486,990 shares of resTORbio Inc. (TORC).